Related Experiment Video
Updated: May 3, 2026
10:12
A Novel Surgical Approach for Intratracheal Administration of Bioactive Agents in a Fetal Mouse Model
Published on: October 31, 2012
16.0K
Methods for retrovirus-mediated gene transfer to fetal lung
B R Pitt1, M A Schwarz, R D Bland
1Department of Pharmacology, University of Pittsburgh School of Medicine, Pittsburgh, PA.
Methods in Molecular Medicine
|February 5, 2014
Summary
Prenatal gene therapy offers a promising approach for treating inherited disorders like cystic fibrosis. This review explores the potential of in utero gene transfer to the fetal lung using retroviral vectors in large animal models.
Area of Science:
- Medical Genetics
- Developmental Biology
- Gene Therapy
Background:
- Somatic gene therapy applications are expanding, primarily in postnatal patients.
- There is growing interest in prenatal applications of somatic gene therapy.
- Inherited disorders present a significant need for novel therapeutic strategies.
Purpose of the Study:
- To review the theoretical, ethical, and experimental basis for in utero gene therapy.
- To outline the methodology for retrovirus-mediated gene transfer to the fetal lung.
- To present findings from a large animal model for prenatal gene therapy.
Main Methods:
- Review of existing literature on in utero gene therapy.
- Development and application of retrovirus-mediated gene transfer techniques.
- Utilizing a large animal model to study fetal lung gene therapy.
Main Results:
- The chapter reviews the rationale and supporting evidence for prenatal gene therapy.
- Methodology for retroviral gene transfer to the fetal lung is detailed.
- A large animal model is employed to assess feasibility and safety.
Conclusions:
- Prenatal somatic gene therapy holds significant potential for treating congenital diseases.
- In utero gene transfer to the fetal lung is a viable strategy being explored.
- Further research in large animal models is crucial for advancing this therapeutic approach.
